Aditxt (NASDAQ:ADTX) Major Shareholder Financial Lp Hrt Sells 735,462 Shares

Aditxt, Inc. (NASDAQ:ADTX) major shareholder Financial Lp Hrt sold 735,462 shares of Aditxt stock in a transaction on Friday, June 5th. The stock was sold at an average price of $0.06, for a total transaction of $44,127.72. Following the transaction, the insider directly owned 505,302 shares of the company’s stock, valued at approximately $30,318.12. This trade represents a 59.27% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Large shareholders that own more than 10% of a company’s stock are required to disclose their transactions with the SEC.

Financial Lp Hrt also recently made the following trade(s):

• On Thursday, June 4th, Financial Lp Hrt acquired 843,622 shares of Aditxt stock. The stock was bought at an average cost of $0.08 per share, for a total transaction of $67,489.76.
• On Friday, April 24th, Financial Lp Hrt sold 1,089 shares of Aditxt stock. The stock was sold at an average price of $7.56, for a total transaction of $8,232.84.
• On Thursday, April 23rd, Financial Lp Hrt sold 141 shares of Aditxt stock. The stock was sold at an average price of $7.83, for a total transaction of $1,104.03.
• On Tuesday, April 21st, Financial Lp Hrt purchased 2,700 shares of Aditxt stock. The stock was bought at an average price of $8.91 per share, for a total transaction of $24,057.00.
• On Wednesday, April 22nd, Financial Lp Hrt sold 443 shares of Aditxt stock. The shares were sold at an average price of $8.10, for a total transaction of $3,588.30.

Aditxt Stock Down 19.6%

Shares of ADTX stock opened at $0.05 on Tuesday. The firm has a 50 day moving average price of $7.33 and a two-hundred day moving average price of $164.13. The company has a market capitalization of $40,918.00, a PE ratio of 0.00 and a beta of 0.84. Aditxt, Inc. has a 12-month low of $0.05 and a 12-month high of $53,451.08.

Aditxt (NASDAQ:ADTX) last issued its quarterly earnings data on Tuesday, March 31st. The company reported $315,563.31 earnings per share (EPS) for the quarter. Aditxt had a negative return on equity of 374.60% and a negative net margin of 360,152.50%.

Analysts Set New Price Targets

ADTX has been the topic of several recent research reports. Wall Street Zen upgraded Aditxt to a “sell” rating in a research report on Saturday, May 23rd. Weiss Ratings reissued a “sell (e+)” rating on shares of Aditxt in a research report on Monday, April 20th. One investment analyst has rated the stock with a Sell rating, According to MarketBeat, the company currently has a consensus rating of “Sell”.

About Aditxt

Aditxt, Inc is a clinical-stage biotechnology company focused on the development and commercialization of natural antimicrobial peptides and microbiome-based detection technologies. Leveraging proprietary peptide libraries, the company aims to provide novel solutions for infection prevention and control across healthcare, food safety, animal health and agricultural markets. Aditxt’s approach centers on harnessing peptides that can disrupt microbial cell membranes without promoting resistance, addressing a growing need for alternatives to traditional antibiotics and chemical disinfectants.

The company’s product offerings include contract-based microbial detection and identification services, designed to help hospitals, food processors and other regulated industries monitor contamination levels and validate hygiene protocols.